Detecting Cancer’s Methylation Fingerprint in Blood Plasma

Detecting Cancer’s Methylation Fingerprint in Blood Plasma

Since 2012, Universal Diagnostics has been working to revolutionize early cancer detection. To make their high-throughput, NGS-based assay a reality, they needed a reputable, trustworthy source of custom panels for hybrid capture. They found the source they were looking for — as well as an enthusiastic research partner — in Twist Bioscience.

Covered in this Case Study

  • Learn how DNA circulating in the blood can be used to detect cancer with just a 9 ml sample
  • Learn how Methylation Patterns on circulating tumor DNA can uncover cancer early
  • Read about how Universal Diagnostics are using Twist Bioscience's NGS tools to detect cancer

Share your details to Get the Case Study

Related Resources